Completed Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers NCT03452332 Conditions Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma, Advanced Vulvar Carcinoma, +50 more Locations UT Southwestern/Simmons Cancer Center-Dallas — Dallas, Texas, United States M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer NCT02595879 Conditions Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma, +23 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States Los Angeles General Medical Center — Los Angeles, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States Keck Medical Center of USC Pasadena — Pasadena, California, United States View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
